Kaltenbach, 57, will be responsible for continuing to drive the company's category innovation strategy and leading all research and development (R&D) activities, including executing the current innovation pipeline and developing the future product portfolio.
'Patrick has distinguished himself throughout nearly three decades in R&D management and business leadership, making him an ideal candidate to continue our drive toward category innovation in alignment with our strategy to Grow, Simplify, and Empower,' said
Kaltenbach joined BD as president of the Life Sciences segment in
As CTO, Kaltenbach will also oversee the company's recently launched 'Innovation and Growth Fund' to advance BD's strategy and increase investments in priority R&D programs that accelerate growth.
Kaltenbach succeeds
'John's impact over his 35-year career goes well beyond 'what' he delivered, but 'how' he did it: With a deep understanding of our customers and their challenges and an unwavering commitment to quality, talent development, and inclusion and diversity,' said Polen. 'We are thankful for his countless accomplishments and the significant impact he's made at BD and throughout patient care around the world.'
DeFord will continue to serve as an advisor and technical and scientific consultant for BD upon his retirement.
Succeeding Kaltenbach as executive vice president and president of the Life Sciences segment is
'I'm confident Dave is the right successor to lead the Life Sciences segment at this critical time for the industry and for public health,' said Polen. 'Throughout nearly 30 years of experience in the life sciences field, Dave has consistently delivered high performance and he has proven himself as an empathetic, passionate and transformative leader of customer-centric teams. Dave's leadership in the Diagnostics space has been on full display during the pandemic, as his team rallied around our purpose and delivered innovative laboratory and point-of-care COVID-19 testing solutions in record time.'
Hickey joined BD in 2014 as vice president and general manager for the Clinical Microbiology business and was promoted to president of the Diagnostics Systems business in 2016. Prior to BD, Hickey spent 22 years with
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.
Contact:
Tel: 201.847.5657
Email: Kristen.Cardillo@bd.com
(C) 2020 Electronic News Publishing, source